🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Henry Schein, Inc. HSIC SPX

Healthcare · Medical Distribution · United States
https://www.henryschein.com

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

READ MORE ›
$76.58
+9.42% 1Y

Market & Price

Market Cap
$8.72B
Current Price
$76.58
High / Low (52W)
$83.35 / $62.03
Beta
0.82

Valuation

Stock P/E
23.14
Industry PE
23.65
Forward P/E
12.96
PEG Ratio
1.68
Book Value
$28.54
Price to Book
2.68
P/S
0.65
EV/EBITDA
13.26
Dividend Yield
-

Profitability & Returns

ROCE
8.55%
ROE
8.76%
ROA
4.35%
Profit Margin
2.95%
Op Margin
5.85%
EPS (Latest Qtr)
$0.92
EPS (TTM)
$3.31

Balance Sheet & Liquidity

Debt/Equity
0.78
Quick Ratio
0.56
Current Ratio
1.36
Debt
$3.75B
Total Assets
$11.21B
Current Assets
$4.46B
Working Capital
$1.24B

Ownership

Promoter Holding
0.82%
Chg in Prom Hold
0.03%
FII / Inst Holding
108.14%
Chg in FII Hold
-0.00%

Financial Snapshot

Enterprise Value
$13.89B
Total Revenue (TTM)
$13.38B
EBITDA
$1.05B
Free Cash Flow
$290.12M
Operating Cash Flow
$578.00M
Shares Outstanding
113.92M
Gross Margin
31.19%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
1.40%
Profit 5Y
-9.56%
Revenue (YoY)
6.30%
Earnings (YoY)
4.50%

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Earnings shrank at -9.6% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 HSIC Henry Schein, Inc. SPX 76.58 23.14 $8.72B - 8.55% 8.76% 1.40% -9.56%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Apr 2017Jul 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Apr 2023Jul 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ----------2.27B2.32B2.36B2.47B2.36B2.45B9.99B2.67B2.43B1.68B2.84B3.17B2.92B2.97B3.18B3.18B3.03B3.07B3.06B3.10B3.16B3.17B3.14B3.17B-3.17B3.24B3.34B3.44B3.37B
Cost of Revenue -----------------------------------2.17B2.22B2.31B2.37B2.30B
Gross Profit 748.91M799.28M777.84M801.47M787.67M859.49M822.92M839.17M836.05M900.96M719.13M718.33M722.36M750.93M751.69M767.43M761.17M810.60M746.01M454.27M754.27M859.71M891.00M891.00M912.00M973.00M945.00M914.00M966.00M975.00M995.00M1.01B1.02B993.00M-1.00B1.02B1.03B1.06B1.07B
Operating Expenses -----------------------------------800.00M842.00M828.00M877.00M876.00M
Operating Income 188.88M200.69M176.19M180.68M200.72M213.98M193.97M210.66M213.55M241.19M162.24M157.11M123.27M158.00M172.44M162.29M187.20M196.33M173.87M-7.43M187.67M181.20M230.00M210.00M211.00M244.00M220.00M211.00M175.00M201.00M200.00M150.00M159.00M157.00M-200.00M174.00M198.00M186.00M194.00M
EBITDA -----------------------------------253.00M235.00M252.00M241.00M270.00M
Interest Expense -----------------------------------35.00M38.00M38.00M39.00M39.00M
Pretax Income -----------------------------------145.00M121.00M134.00M133.00M150.00M
Tax Provision -----------------------------------35.00M31.00M28.00M32.00M38.00M
Net Income 127.73M129.95M113.75M120.10M133.71M139.22M140.75M136.06M138.03M-8.54M111.53M110.64M90.77M117.78M109.78M114.53M140.56M330.61M130.26M-10.80M141.70M-166.00M156.00M162.00M181.00M160.00M150.00M121.00M140.00M137.00M93.00M104.00M99.00M-110.00M86.00M101.00M101.00M107.00M
Diluted EPS 1.521.560.690.730.820.860.880.860.87-0.060.720.720.590.770.780.780.912.250.91-0.080.990.991.161.101.151.301.161.090.911.061.050.720.800.78-0.880.700.840.850.92

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ---------8.88B9.42B9.99B10.12B-12.65B12.34B12.67B13.18B
Cost of Revenue --------------8.82B8.48B8.66B9.08B
Gross Profit 1.87B1.92B2.17B2.42B2.51B2.66B2.91B3.01B3.23B2.75B2.91B3.09B2.82B-3.83B3.86B4.02B4.11B
Operating Expenses --------------2.95B3.17B3.29B3.35B
Operating Income 419.29M464.08M521.13M582.15M618.96M677.05M715.14M733.97M771.57M669.76M600.62M718.26M535.00M-878.00M695.00M731.00M758.00M
EBITDA --------------950.00M851.00M912.00M964.00M
Interest Expense --------------35.00M87.00M131.00M150.00M
Pretax Income --------------721.00M542.00M513.00M533.00M
Tax Provision --------------170.00M120.00M128.00M126.00M
Net Income 239.46M311.15M325.79M367.66M388.08M431.55M466.08M479.06M506.78M406.30M535.88M694.73M404.00M-538.00M416.00M390.00M398.00M
Diluted EPS 2.633.443.493.974.324.935.442.853.102.573.494.652.82-3.913.163.053.27

Compounded Sales Growth

5 Years:1.40%
1 Year:6.30%

Compounded Profit Growth

5 Years:-9.56%
1 Year:4.50%

Stock Price Performance

1 Year:+9.42%
6 Months:+1.43%
3 Months:-7.05%
1 Month:+3.77%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -3.60B3.84B4.55B4.74B5.33B5.62B6.14B6.53B6.81B7.86B8.50B7.15B7.77B-8.61B10.57B10.22B11.21B
Current Assets ---------------3.99B4.49B3.98B4.46B
Cash & Equivalents 247.59M369.57M471.15M150.35M147.28M122.08M188.62M89.47M72.09M62.38M174.66M80.21M---117.00M171.00M122.00M156.00M
Inventory ---------------1.96B1.81B1.81B2.00B
Receivables ---------------1.44B1.86B1.48B1.65B
Total Liabilities --1.50B1.83B1.90B2.28B2.34B2.76B3.08B3.35B4.21B4.65B3.23B3.46B-3.94B5.42B5.38B6.42B
Current Liabilities --1.08B1.17B1.27B1.47B1.55B1.78B2.15B2.32B2.83B3.22B2.04B2.28B-2.22B2.68B2.80B3.23B
Long Term Debt --243.37M395.31M363.52M----------1.04B1.94B1.83B2.31B
Total Debt ---------------1.50B2.74B2.87B3.44B
Total Equity --2.16B2.41B2.43B2.61B2.79B2.81B2.88B2.79B2.81B2.96B3.00B3.35B-3.45B3.65B3.39B3.25B
Shares Outstanding ---------------131.79M129.25M124.16M115.77M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 384.78M398.03M395.48M554.62M408.10M--615.50M642.58M545.51M684.71M654.09M599.00M-602.00M500.00M848.00M712.00M
Investing Cash Flow -168.01M-98.59M-387.62M-193.22M-269.60M---260.03M-316.42M-342.28M-192.95M-424.37M-115.00M--276.00M-1.14B-430.00M-400.00M
Financing Cash Flow -87.97M-197.68M-330.64M-357.21M-170.60M---348.03M-327.34M-112.55M-603.78M-215.98M-187.00M--315.00M701.00M-510.00M-188.00M
Capital Expenditure ---------------128.00M-187.00M-187.00M-191.00M
Free Cash Flow --------------474.00M313.00M661.00M521.00M
Net Change in Cash --------------11.00M66.00M-92.00M124.00M
Share Buybacks 82.79M057.73M200.00M299.88M300.25M299.99M299.85M550.02M450.00M200.00M525.00M74.00M401.00M485.00M250.00M385.00M850.00M

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ---------30.9%30.9%31.0%27.8%-30.3%31.3%31.7%31.1%
Operating Margin % ---------7.5%6.4%7.2%5.3%-6.9%5.6%5.8%5.7%
Net Margin % ---------4.6%5.7%7.0%4.0%-4.3%3.4%3.1%3.0%
ROE % -14.4%13.5%15.1%14.8%15.5%16.6%16.6%18.1%14.5%18.1%23.2%12.1%-15.6%11.4%11.5%12.3%
ROCE % -16.8%15.4%16.8%16.0%16.6%16.4%16.7%17.2%13.3%11.4%14.0%9.7%-13.8%8.8%9.9%9.5%

Shareholding Pattern

Insiders
0.82%
Institutions
108.14%
Public Float
109.02%

Top Institutional Holders

#Holder% HeldSharesValue
1 Kohlberg Kravis Roberts & Co. L.P. 13.74% 15.65M $1.20B
2 Blackrock Inc. 6.17% 7.02M $537.82M
3 Artisan Partners Limited Partnership 5.77% 6.57M $503.36M
4 Vanguard Capital Management LLC 5.64% 6.42M $491.89M
5 FMR, LLC 5.02% 5.72M $438.20M
6 Invesco Ltd. 4.29% 4.89M $374.21M
7 JPMORGAN CHASE & CO 4.01% 4.56M $349.40M
8 State Street Corporation 3.84% 4.38M $335.34M
9 Vanguard Portfolio Management LLC 3.68% 4.19M $321.25M
10 American Century Companies Inc 3.16% 3.59M $275.26M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HSIC

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks